Chinese Bio Technology Company Ionova Raised ¥126 Million in a Series A Round Funding Led by Lilly Asia Ventures

0
Chinese Bio Technology Company Ionova Raised ¥126 Million in a Series A Round Funding Led by Lilly Asia Ventures
Chinese Bio Technology Company Ionova Raised ¥126 Million in a Series A Round Funding Led by Lilly Asia Ventures

Chinese bio technology Company Ionova Raised ¥126 Million in a Series A Round Funding Led by Lilly Asia Ventures and followed by Dyee Capital. The investment will be used to advance projects into clinical research, and accelerate R&D.

Established in 2016, Ionova is committed to the R&D of innovative targeted agents for tumors and immune regulation drugs for tumor.

South Africa Today


Read more at VolaNews

Disclaimer: The views of authors published on South Africa Today are their own and do not necessarily represent the views of South Africa Today. By viewing, visiting, using, or interacting with SouthAfricaToday.net, you are agreeing to all the provisions of the Terms of Use Policy and the Privacy Policy.